Literature DB >> 1465642

Magnetic resonance imaging of myositis ossificans: analysis of seven cases.

A A De Smet1, M A Norris, D R Fisher.   

Abstract

Myositis ossificans typically presents as soft tissue swelling with progressive ossification on radiographs. Since magnetic resonance imaging (MRI) is commonly used to evaluate soft tissue masses, we analyzed eight MR examinations in seven patients with myositis ossificans to determine if typical patterns were present. One acute lesion had homogeneous intermediate signal intensity on T1-weighted images and high signal intensity on T2-weighted images. Two subacute lesions had low signal intensity margins with slightly increased signal intensity centers on T1-weighted images and very high signal intensity on T2-weighted images. Five chronic lesions had two different patterns. All five were well-defined with low signal intensity borders. Three had signal intensity patterns characteristic of fat on T1-weighted and T2-weighted images. The other two lesions had intermediate signal intensity on T1-weighted images and slightly increased signal intensity on T2-weighted images. We conclude that typical MR appearances of myositis ossificans do exist. A low signal intensity rim is a common finding. However, these patterns are not unique to myositis ossificans and resemble those that have been reported in other lesions. It is important to be aware of the spectrum of MR findings of myositis ossificans when considering the differential diagnosis of a soft tissue mass.

Entities:  

Mesh:

Year:  1992        PMID: 1465642     DOI: 10.1007/bf00195231

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  11 in total

1.  Cases of the day. Pediatric. Myositis ossificans circumscripta.

Authors:  S L Hanna; H L Magill; M T Brooks; E M Burton; T F Boulden; F G Seidel
Journal:  Radiographics       Date:  1990-09       Impact factor: 5.333

2.  Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions.

Authors:  T H Berquist; R L Ehman; B F King; C G Hodgman; D M Ilstrup
Journal:  AJR Am J Roentgenol       Date:  1990-12       Impact factor: 3.959

3.  Pseudomalignant myositis ossificans. Clinical, radiologic, and cytologic diagnosis in 5 cases.

Authors:  B Rööser; K Herrlin; A Rydholm; M Akerman
Journal:  Acta Orthop Scand       Date:  1989-08

4.  Case report 694: Cervical paravertebral circumscribed myositis ossificans.

Authors:  F López Barea; J L Rodriguez Peralto; J Gonzalez López; F Sanchez Perez Grueso
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

Review 5.  Quadriceps contusions. West Point update.

Authors:  J B Ryan; J H Wheeler; W J Hopkinson; R A Arciero; K R Kolakowski
Journal:  Am J Sports Med       Date:  1991 May-Jun       Impact factor: 6.202

6.  Multimodality imaging of early heterotopic bone formation.

Authors:  N R Laurin; J E Powe; W F Pavlosky; A A Driedger
Journal:  Can Assoc Radiol J       Date:  1990-04       Impact factor: 2.248

Review 7.  MR imaging of tumor and tumorlike lesions of bone and soft tissue.

Authors:  M Sundaram; R A McLeod
Journal:  AJR Am J Roentgenol       Date:  1990-10       Impact factor: 3.959

8.  Pseudomalignant, nonneoplastic osseous soft-tissue tumors of the hand and foot.

Authors:  H E Schütte; R O van der Heul
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

9.  Myositis ossificans: MR appearance with radiologic-pathologic correlation.

Authors:  M J Kransdorf; J M Meis; J S Jelinek
Journal:  AJR Am J Roentgenol       Date:  1991-12       Impact factor: 3.959

Review 10.  The management of athletes with myositis ossificans traumatica.

Authors:  D W Booth; B M Westers
Journal:  Can J Sport Sci       Date:  1989-03
View more
  26 in total

Review 1.  Indeterminate soft-tissue tumors of the hand and wrist: a review based on a clinical series of 39 cases.

Authors:  Paul A Sookur; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2010-07-31       Impact factor: 2.199

Review 2.  Intramuscular granular cell tumor: emphasizing the stripe sign.

Authors:  Eun Sil Kim; Seun Ah Lee; Baek Hyun Kim; Chul Hwan Kim
Journal:  Skeletal Radiol       Date:  2015-09-10       Impact factor: 2.199

Review 3.  Heterotopic ossification: a review.

Authors:  E F McCarthy; M Sundaram
Journal:  Skeletal Radiol       Date:  2005-08-25       Impact factor: 2.199

4.  Myositis ossificans: the mimicker.

Authors:  Arunkumar Govindarajan; Radha Sarawagi; Manikka Lakshmanan Prakash
Journal:  BMJ Case Rep       Date:  2013-12-10

Review 5.  Post-traumatic ectopic calcification in the muscles of athletes: a review.

Authors:  J B King
Journal:  Br J Sports Med       Date:  1998-12       Impact factor: 13.800

6.  MR imaging and ultrasonography findings of early myositis ossificans: a case report.

Authors:  Kyung Ryeol Lee; So Young Park; Wook Jin; Kyu Yeoun Won
Journal:  Skeletal Radiol       Date:  2016-08-10       Impact factor: 2.199

7.  Calcific myonecrosis: a report of ten new cases with an emphasis on MR imaging.

Authors:  M Dhillon; A M Davies; J Benham; N Evans; D C Mangham; R J Grimer
Journal:  Eur Radiol       Date:  2004-10-06       Impact factor: 5.315

8.  Proliferative myositis in a patient with AIDS.

Authors:  B Wlachovska; B Abraham; J F Deux; M Sibony; C Marsault; C Le Breton
Journal:  Skeletal Radiol       Date:  2003-12-04       Impact factor: 2.199

Review 9.  Soft-tissue tumors update: MR imaging features according to the WHO classification.

Authors:  Joan C Vilanova; Klaus Woertler; José A Narváez; Joaquim Barceló; Salutario J Martínez; Miguel Villalón; Josefina Miró
Journal:  Eur Radiol       Date:  2006-02-18       Impact factor: 5.315

10.  Muscle functional magnetic resonance imaging and acute low back pain: a pilot study to characterize lumbar muscle activity asymmetries and examine the effects of osteopathic manipulative treatment.

Authors:  Brian C Clark; Stevan Walkowski; Robert R Conatser; David C Eland; John N Howell
Journal:  Osteopath Med Prim Care       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.